GCTK Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
0
0
0
0
0
Cost of Revenue
0
0
0
0
0
Gross Profit
0
0
0
0
0
Operating Expenses
3.4M
-19.1%
4.2M
+20.5%
3.5M
-19.1%
4.3M
-10.2%
4.8M
R&D
2.0M
-5.4%
2.1M
+31.0%
1.6M
-48.6%
3.2M
+0.5%
3.1M
SG&A
1.4M
-33.2%
2.1M
+11.3%
1.9M
+62.6%
1.1M
-30.5%
1.6M
Operating Income
-3400000
+19.1%
-4203000
-20.5%
-3487000
+19.1%
-4309000
+10.2%
-4796000
EBITDA
-3379000
+19.2%
-4181000
-20.4%
-3473000
+19.2%
-4300000
+10.1%
-4785000
Net Income
-3814000
+12.0%
-4334000
-19.5%
-3628000
+13.0%
-4171000
+12.3%
-4756000
EPS (Basic)
$-11.40
+71.3%
$-39.75
+32.7%
$-59.08
+15.1%
$-69.60
+51.8%
$-144.30
EPS (Diluted)
$-11.40
+71.3%
$-39.75
+32.7%
$-59.08
+15.1%
$-69.60
+51.8%
$-144.30
Shares (Diluted)
333.9K
+205.8%
109.2K
+77.8%
61.4K
+2.4%
60.0K
+81.9%
33.0K
GlucoTrack (GCTK) โ€” Financials